Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Febrile Neutropenia × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2 Urinary Bladder Neoplasms 1 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Mucositis 1 Lung Neoplasms 1 Insulin Resistance 1 Hyperphagia 1 Hyperglycemia 1 Febrile Neutropenia 1 Emergence Delirium 1

Interventions

Meropenem 4 Ceftazidime 4 Vancomycin 3 Levofloxacin 2 Ciprofloxacin 2 Cefepime 2 ceftolozane, tazobactam drug combination 1 Vaccination 1 Teicoplanin 1 Tazobactam 1 Simvastatin 1 Pneumococcal Vaccines 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Micafungin 1 Injections 1 Filgrastim 1 Anti-Bacterial Agents 1 Amoxicillin-Potassium Clavulanate Combination 1 Amikacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡